Targeted retrograde gene delivery to motor neurons

Details for Australian Patent Application No. 2002364221 (hide)

Owner The Salk Institute for Biological Studies

Inventors Kaspar, Brian K.; Rothstein, Jeffrey D.; Peterson, Daniel; Gage, Fred H.

Agent Griffith Hack

Pub. Number AU-B-2002364221

PCT Number PCT/US02/41194

PCT Pub. Number WO2003/055983

Priority 10/237,567 05.09.02 US; 10/032,047 21.12.01 US

Filing date 20 December 2002

Wipo publication date 15 July 2003

Acceptance publication date 10 July 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 10/237,567 05.09.02 US; 10/032,047 21.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002364221

3 April 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to include coinventor Rothstein, Jeffrey D.

10 July 2008 Application Accepted

  Published as AU-B-2002364221

6 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364222-Plant cyclopropane fatty acid synthase genes, proteins and uses thereof

2002364220-PREFORM FOR MAKING A NONREFILLABLE BOTTLE FOR NONCARBONATED LIQUIDS